openPR Logo
Press release

Axon Development Inc. Appoints Keerti Sourav Namani as New COO

08-23-2024 07:24 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Axon Development Inc. Appoints Keerti Sourav Namani as New COO

Axon Development Inc. aims to Improve the Residential Construction Industry, Expand Market Reach, and Drive Operational Excellence.
Image: https://www.abnewswire.com/uploads/fe84437df1ef5207a23c09348fb498a1.png

Axon Development Inc., a reputable residential development and real estate company, has announced the appointment of Keerti Sourav Namani as Chief Operating Officer (COO), effective August 2024. Sourav, who began their career as an Operations Manager and was promoted to Head of Operations before assuming the COO role, brings a wealth of experience to this newly filled position.

Under Sourav's leadership, Axon is poised to venture into new markets in the Sunbelt region, including cities such as Phoenix, Austin, Houston, and Dallas, aiming to expand its reach and influence. Axon aims to be a significant part of the solution to the housing shortage problem, focusing on data-driven decision-making and a first-principles approach.

The company's strategic vision is ambitious yet straightforward: to drive innovation and operational excellence, aiming for a 30% increase in revenue and a substantial boost in profitability. Sourav's approach includes incorporating new technologies, from AI and automation to enhancing operational efficiency and streamlining processes.

Expressing his enthusiasm for the new role, Sourav stated, "I am privileged to take on the role of COO at Axon Development Inc. and excited to guide our exceptional team as we shape the future of the residential construction industry and venture into new markets."

Under the joint leadership of CEO Vy Tran and the new COO Keerti Sourav Namani, Axon has already seen high employee retention rates due to a positive work environment and employee-centric policies. These efforts have increased employee satisfaction and loyalty.

Additionally, operational expenses have been reduced by approximately 14% through strategic partnerships and cost-saving measures, and the company has successfully entered the commercial construction sector, fulfilling a long-standing objective.

Keerti Sourav Namani's focus remains on furthering Axon's digital transformation initiatives, expanding its market presence, and fostering a culture of innovation and teamwork.

For more details, visit: https://www.axon-development.com/ or contact Ruby Docot at ruby@axon-development.com

Media Contact
Company Name: Axon Development Inc.
Contact Person: Ruby Docot
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=axon-development-inc-appoints-keerti-sourav-namani-as-new-coo]
City: Fort Worth
State: Texas
Country: United States
Website: http://www.axon-development.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Axon Development Inc. Appoints Keerti Sourav Namani as New COO here

News-ID: 3633260 • Views:

More Releases from ABNewswire

Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our
Retinal Vein Occlusion Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Retinal Vein Occlusion Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Retinal Vein Occlusion Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Retinal Vein Occlusion pipeline landscape. It covers the Retinal Vein Occlusion pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Retinal Vein Occlusion pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore

All 5 Releases


More Releases for Axon

Crime Risk Market Massive Growth opportunity Ahead | Axon, Darktrace, Esri
The Latest Released Global Crime Risk market study has evaluated the future growth potential of Global Crime Risk market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision-makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, and emerging trends along with essential
Investigation announced for Investors in Axon Enterprise, Inc. (NASDAQ: AXON) ov …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Axon Enterprise, Inc. . Investors who purchased shares of Axon Enterprise, Inc. (NASDAQ: AXON) a have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Axon Enterprise, Inc. officers and directors breached their fiduciary duties and caused damage to the
Blind Ram BOP Market | Axon, BHGE, BOP Products, Control Flow
The global blind ram bop market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the blind ram bop market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
GovTech Market to See Competition Rise | Axon, MicroTraffic, Viselio
The Latest published a market study on Global GovTech Market provides an overview of the current market dynamics in the GovTech space, as well as what our survey respondents- all outsourcing decision-makers- predict the market will look like in 2027. The study breaks the market by revenue and volume (wherever applicable) and price history to estimate the size and trend analysis and identify gaps and opportunities. Some of the players
Biometrics Banking Market Next Big Thing | Biolink Solutions, Axon Wireless
Global Biometrics Banking Market Size, Status and Forecast 2019-2025 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Biometrics Banking Market. Some of the key players profiled in the study are Techshino Technology, State
axon IT Awarded Microsoft Cloud Accelerate Partner Status
IT giant Microsoft has made Macclesfield-based IT solutions provider axon IT a Microsoft Cloud Accelerate Partner in recognition of the firms accomplishments in providing Microsoft cloud computing solutions to its customers. The accreditation comes just six months after a previous Microsoft endorsement, when axon IT became the first business in the North West to be awarded Microsoft Gold Partner status with virtualization competency. Launched in 2010, the exclusive Microsoft Cloud Accelerate